¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"back diffusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back
    µî
  • back blow
    µîµÎµå¸®±â(¹ý), µîŸ°Ý(¹ý)
  • back flow
    ¿ª·ù, °Å²ÜÈ帧
  • back mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • back pain
    µîÅëÁõ
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • back rest
    µî¹Þħ
  • back scattering
    ÈĹæ»ê¶õ
  • back-flush needle
    µÇ½î±â¹Ù´Ã
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • dying-back
    ¿ªÇà»ç
  • failed back surgery syndrome
    ôÃß¼ö¼úÈÄ¿äÅëÁõÈıº
  • hollow back
    ôÁÖ¾Õ±ÁÀ½(Áõ), ôÁÖÀü¸¸
  • low back pain
    Ç㸮ÅëÁõ, ¿äÅë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back pain
    ¿äÅë, µîÅëÁõ
  • diffusion
    È®»ê
  • simple diffusion
    ´Ü¼øÈ®»ê
  • diffusion time
    È®»ê½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • back
    µî
  • back blow
    µîŸ°Ý(¹ý)
  • back flow
    ¿ª·ù, °Å²ÜÈ帧, µÚÈ帧
  • back height
    µî¹ÞÀ̳ôÀÌ
  • back mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • back pain
    ¿äÅë, µîÅëÁõ
  • back rest
    µî¹Þħ
  • back scattering
    ÈĹæ»ê¶õ
  • back strength
    µîÈû
  • back-flush needle
    µÇ½î±â¹Ù´Ã
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • blow back effect
    µÞ¹Ù¶÷È¿°ú, ÈÄdzȿ°ú
  • hollow back
    (¢¡lordosis) ôÁÖ¾Õ±ÁÀ½Áõ, ôÁÖÀü¸¸
  • poker back
    (¢¡ankylosing spondylitis) °­Á÷ôÃß¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hollow back =lordosis
    (ôÃß) Àü¸¸(Áõ)(ô±õÐîñضñø), ôÁÖÀü°ñ.
  • hollow back =lordosis
    (ôÃß)Àü¸¸(Áõ)(ô±õÐîñضñø), ôÁÖÀü°ñ.
  • positive feed back
    ¾ç¼ºµÇ¸ÔÀ̱â.
  • pyelointerstitial back flow
    ½Å¿ì°£Áú¼º¿ª·ù
  • pyelotubular back flow
    ½Å¿ì¼¼¿ä°ü¼º¿ª·ù
  • ADC (apparent diffusion coefficient)
    °Ñº¸±â È®»ê °è¼ö
  • Ficks law of diffusion
    ÇÈÀÇ È®»ê(üªß¤)¹ýÄ¢(ÛööÎ)
  • Oudins agar diffusion
    ¿ìµ­ ÇÑõȮ»ê¹ý
  • agar diffusion
    ÇÑõ(³»)È®»ê(¡­üªß¤).
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar gel diffusion
    ÇÑõ°ÖÈ®»ê(ùÎô¸¡­üªß¤).
  • anisotropic diffusion
    ºñµî¹æ¼º È®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
  • apparent diffusion coefficient (ADC)
    °Ñº¸±â È®»ê °è¼ö
  • free diffusion
    ÀÚÀ¯È®»ê.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back diffusion
    ¿ªÈ®»ê(æ½üªß¤)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agar diffusion
    ÇÑõ(³»)È®»ê(¡­üªß¤).
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar gel diffusion
    ÇÑõ°ÖÈ®»ê(ùÎô¸¡­üªß¤).
  • anisotropic diffusion
    ºñµî¹æ¼º È®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
  • apparent diffusion coefficient (ADC)
    °Ñº¸±â È®»ê °è¼ö
  • carrier mediated diffusion
    ´ãü(¸Å°³) È®»ê.
  • circle of diffusion
    »ê¶õ¿ø, Âø¶õ¿ø
  • circulatory diffusion
    ¼øÈ¯È®»ê(¡­üªß¤) ¡ì¿ëÇØ¹ý(éÁú°Ûö)¡í.
  • column diffusion method
    ±âµÕ È®»ê ¹æ¹ý
  • diffusion
    È®»ê
  • diffusion
    È®»ê(üªß¤), ¹Ì»ê(گߤ).
  • diffusion anoxia
    È®»ê¼º ¹«»ê¼Ò(Áõ)(üªß¤àõÙíß«áÈñø).
  • diffusion barrier
    È®»êÀ庮(¡­î¡Ûú).
  • diffusion capacity
    È®»ê´É(üªß¤Òö)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Back of thigh
    ³ÐÀû´Ù¸®µÚºÎÀ§
    [¿¾ ¿ë¾î] ÈÄ´ëÅðºÎ,´ëÅðÈĸé
  • Back
    µî
    [¿¾ ¿ë¾î] µî,¹è
  • Back of knee
    ¹«¸­µÚºÎÀ§
    [¿¾ ¿ë¾î] ÈĽ½ºÎ
  • Back of ankle
    ¹ß¸ñµÚºÎÀ§
    [¿¾ ¿ë¾î] -
  • Back of forearm
    ¾Æ·¡ÆÈµÚºÎÀ§
    [¿¾ ¿ë¾î] ÈÄÀü¿ÏºÎ
  • Back of arm
    À§ÆÈµÚºÎÀ§
    [¿¾ ¿ë¾î] ÈÄ»ó¿ÏºÎ
  • Back of leg
    Á¾¾Æ¸®µÚºÎÀ§
    [¿¾ ¿ë¾î] ÈÄÇÏÅðºÎ
  • Back of elbow
    ÆÈ²ßµÚºÎÀ§
    [¿¾ ¿ë¾î] ÈÄÁÖºÎ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back mutation
    º¹±Íº¯ÀÌ(ÜÖÏýܨì¶)
  • back titration
    ¿ªÀûÁ¤(æ½îêïÒ)
  • agar diffusion method
    ÇÑõȮ»ê¹ý(ùÎô¸üªß¤Ûö)
  • carrier-facilitated diffusion
    ij¸®¾î ÃËÁø È®»ê(õµòäüªß¤)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • diffusion
    È®»ê(üªß¤)
  • diffusion chamber
    È®»ê½Ç(üªß¤ãø)
  • diffusion coefficient
    È®»ê°è¼ö(üªß¤Ìõâ¦)
  • diffusion constant
    "È®»ê»ó¼ö(üªß¤ßÈâ¦), (ÔÒ) diffusion coefficient"
  • diffusion-limited reaction
    È®»êÁ¦ÇÑ ¹ÝÀÀ(üªß¤ð¤ùÚÚãëë)
  • diffusion potential
    È®»êÀüÀ§(üªß¤ï³êÈ)
  • double diffusion
    ÀÌÁß È®»ê(ì£ñìüªß¤)
  • eddy diffusion
    ¿ÍÈ®»ê(è¾üªß¤)
  • exchange diffusion
    ±³È¯ È®»ê (Îßüµüªß¤)
  • facilitated diffusion
    ÃËÁøÈ®»ê (õµòäüªß¤)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • back
    ¹èºÎ, ¹è¸é
  • back flow
    ¿ª·ù
  • back pain
    ¹èÅë, ¿äÅë
  • back projection
    ¿ªÅõ»ç
  • low back pain
    ¿äÅë
  • straight back syndrome
    Á÷ôÃßÁõ
  • ADC [=apparent diffusion coefficient]
    °Ñº¸±âÈ®»ê°è¼ö
  • anisotropic diffusion
    ºñµî¹æ¼ºÈ®»ê
  • apparent diffusion coefficient [=ADC]
    °Ñº¸±âÈ®»ê°è¼ö
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • diffusion
    È®»ê, ¹Ì»ê
  • diffusion coefficient
    È®»ê°è¼ö
  • diffusion equation
    È®»êµî½Ä
  • diffusion gradient pulse
    È®»ê°æ»çÆÞ½º
  • diffusion imaging
    È®»ê¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGD agar gel diffusion; agarose diffusion; alpha-ketoglutarate dehydrogenase
DP data processing; deep pulse; definitive procedure; degradation product; degree of polymerization; de...
LBP lipopolysaccharide-binding protein; low back pain; low blood pressure; lumbar back pain
LBS low back syndrome; lumbar back strain
DC   1) Direct Current
  2) Diffusion Capacity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BP Back Propagation
BSE Back scattered electron
CLBP Chronic low back pain
FBSS Failed Back Surgery Syndrome
FBP Filtered Back-Projection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • adolescent round back
    û¼Ò³â±â Èĸ¸Áõ
  • back
    ¹èºÎ, ¹è¸é, µî
    »ý¹°¿¡¼­ ¹è¸é, µî, ÈĸéÀ» ÀǹÌÇÒ »Ó ¾Æ´Ï¶ó, ¹«´ëÀÇ ¹è°æ, ÀÏÀÇ Áø»ó, »êÀÇ µî¼ºÀÌ, ÀÇÀÚÀÇ µî¹ÞÀÌ µîÀ» ¶æÇϱ⵵ ÇÑ´Ù.
  • back knee
    °ú½ÅÀü ½½, ¹ÝÀå ½½, Àü¹Ý ½½, Àü¹ø ½½
  • back pain
    ¹èÅë, ¿äÅë
  • back pressure porosity
    ¹Ý´ë¾Ð ±âÆ÷
  • back scatter factor
    ÈÄ¹æ »ê¶õ °è¼ö
  • back vowel
    ¿À¸ðÀ½
    Èļ³ ¸ðÀ½.
  • back-pressure
    ¿ª·ù¾Ð
  • fall back
    °Ý¼¼ À¯Àü
  • myofascial low back pain
    ±Ù¸·¼º ¿äÅë
    ¿äÅëÀ» ÁַΠȣ¼ÒÇÏ´Â ÁúȯÀÇ ÇϳªÀ̰í ô¼ö ½Å°æÀÌ ¿äºÎ ±Ù¸·À» ¶Õ°í ³ª¿À´Â ºÎÀ§¿¡ ¾ÐÅë ¹× ¿îµ¿ÅëÀÌ ³ªÅ¸³­´Ù. ¿øÀÎÀ¸·Î¼­´Â ±¹¼Ò¿¡¼­ÀÇ ·çĿƼÁò¼³µµ Àִµ¥ ôÃß ºÐ¸®Áõ µî ¿ÜÀÇ ÁúȯÀÎ °æ¿ì¿¡´Â Áõ»óÀ¸·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í °ü·ÃµÇ´Â ÅëÁõ ¿äÀÎÀ̳ª ô¼ö ½Å°æ ÈÄÁöÀÇ Àڱؼº Ç×Áø µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. Ä¡·á·Î¼­´Â ±¹¼Ò ¸¶ÃëÁ¦³ª ½ºÅ×·ÎÀ̵åÁ¦ÀÇ ±¹¼Ò Áֻ簡 ÀÌ·ç¾îÁö°Å³ª ±Ù¸· Àý°³ ³»Áö ÀýÁ¦¼úÀÌ ÀÌ·ç¾îÁö´Â ¼öµµ ÀÖ´Ù.
  • step-back procedure
    Á¡ÁøÀû ÈĹæ À¯µµ¼ú
  • straight back syndrome
    Á÷ôÃßÁõ
  • unilateral back pain
    ÀÏÃø¼º ¹èÅë
  • agar diffusion method
    ÇÑõ È®»ê¹ý, ÇÑõ³» È®»ê¹ý
    ÇÑõÀÇ °Ö ³»¿¡¼­ ħ°­¹ÝÀÀÀ» ÇàÇÏ´Â ¹æ¹ýÀ̰í 2Á¾ ÀÌ»óÀÇ Ç׿ø ¹× Ç×ü°¡ °ü¿©ÇÏ´Â ¹ÝÀÀÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ´Â °ÍÀÌ °¡´ÉÇÏ´Ù. ¹ÝÀÀ ÀÎÀÚÀÇ ¾î´À ÇÑÂÊÀ» ÇÑõ ³»¿¡ ³ì¿©µÎ°í ´Ù¸¥ ÀÎÀÚ¸¦ È®»ê½ÃŰ´Â ´Ü¼ø È®»ê¹ý°ú ÇÑõÀÇ Áß°£Ãþ°ú ¶³¾îÁ®¼­ Ç׿ø°ú Ç×ü¸¦ È®»ê½ÃŰ´Â 2Áß È®»ê¹ý, ±×¸®°í ¸é¿ª Àü±â ¿µµ¿ÀÌ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
ambipolar diffusion <radiobiology> Diffusion process in which buildup of spatial charge creates electric fields which cause electrons and ions to leave the plasma at the same rate. (Such electric fields are self-generated by the plasma and act to preserve charge neutrality.)
(09 Oct 1997)
anomalous diffusion <radiobiology> Diffusion in most plasma devices, particularly tokamaks, is higher than what one would predict from understood causes. The observed, typical diffusion is referred to as anomalous because it has not yet been explained.
Anomalous diffusion includes all diffusion which is not due to collisions and geometric effects. While such effects were not understood when the term was coined, and most still are not, diffusion due to well-understood wave phenomena is still 'anomalous'. Classical diffusion and Neo-classical diffusion are the two well-understood diffusion theories, although neither is adequate to fully explain the observed anomalous diffusion.
See: entries for classical diffusion and neoclassical diffusion. Anomalous resistivity
(09 Oct 1997)
bohm diffusion <radiobiology> A rapid loss of plasma across magnetic field lines caused by microinstabilities. Theory formulated by the physicist David Bohm.
Semiempirical formula for the diffusion coefficient given by Bohm in 1946 (noted by Bohm, Burhop, and Massey, who were developing a magnetic arc for use in uranium isotope separation). Bohm diffusion was proposed (not derived from first principles) to scale as 1/B rather than the 1/B^2 scaling predicted by classical diffusion. A 1/B scaling results from assuming that particles diffuse across field lines at an optimum rate (effective collision frequency=cyclotron frequency). The 1/B scaling is observed (approximately) in most reactors.
See: diffusion, microinstabilities, field lines.
(09 Oct 1997)
gel diffusion Diffusion in a gel, as in the case of gel diffusion precipitin tests in which the immune reactants diffuse in agar.
See: immunodiffusion.
(05 Mar 2000)
gel diffusion precipitin tests Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
gel diffusion precipitin tests in one dimension Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension).
(05 Mar 2000)
gel diffusion precipitin tests in two dimensions Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity.
(05 Mar 2000)
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
passive diffusion See: facilitated transport.
(05 Mar 2000)
classical diffusion <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.)
(09 Oct 1997)
population diffusion coefficient <cell biology> Coefficient that describes the tendency of a population of motile cells to diffuse through the environment. Its use presupposes that the cells move in a random walk.
(18 Nov 1997)
neoclassical diffusion <radiobiology> In a magnetised plasma, _classical_ diffusion refers to transport of particles due to Coulomb collisions, taking the spiral orbits in the magnetic field into account. In a toroidal magnetic field, the actual rate of diffusive transport is much higher due to slow changes in the positions of the centres of the spirals, known as banana orbits.
This faster transport is called _neo-classical_. With very few exceptions the transport in toroidal devices is observed to be 10-100 times larger still, presumably due to small-scale turbulence. The observed transport is called _anomalous_ (although it actually is the normal state).
(09 Oct 1997)
diffusion The process of becoming diffused or widely spread, the spontaneous movement of molecules or other particles in solution, owing to their random thermal motion, to reach a uniform concentration throughout the solvent, a process requiring no addition of energy to the system.
(18 Nov 1997)
diffusion anoxia Diffusion hypoxia severe enough to result in the absence of oxygen in alveolar gas.
(05 Mar 2000)
diffusion chambers, culture Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diffusion
    È®»ê
  • diffusion
    »êÆ÷;À¯Æ÷;º¸±Þ;»ê¸¸
  • diffusion index
    È®»ê Áö¼ö;°æ±â µ¿Çâ Áö¼ö
  • diffusion pump
    È®»ê Áø°ø ÆßÇÁ(°¡½ºÀÇ È®»êÀ» ÀÌ¿ëÇÏ¿© ³ôÀº Áø°øµµ¸¦ ¸¸µê)
  • gaseous diffusion
    ±âü È®»ê¹ý
  • back
    µÚ·Î,ÈÄÅðÇÏ´Ù,µÚÀÇ,µÚ
  • cut back
    Ãà¼ÒÇÏ´Ù
  • drive back
    Â÷¸¦ Ÿ°í µ¹¾Æ¿À´Ù; °ÝÅðÇÏ´Ù
  • fall back on
    ºñ»ó½Ã¿¡ ÀÌ¿ëÇÏ´Ù; ÀÇÁ¸ÇÏ´Ù
  • get back
    µ¹¾Æ°¡´Ù; ¿ø¼ö¸¦ °±´Ù
  • give back
    µ¹·ÁÁÖ´Ù; ²Ç¹«´Ï¸¦ »©´Ù
  • go back
    µÇµ¹¾Æ ¿À´Ù; ´Ù½ÃÇÏ´Ù
  • go back on
    Ãë¼ÒÇÏ´Ù
  • hold back
    Ãë¼ÒÇÏ´Ù; ºñ¹Ð·Î ÇØµÎ´Ù
  • look back on
    ȸ»óÇÏ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á